Smoking Cessation News and Research

RSS

VDF's annual meeting to discuss latest information in vascular disease

The Vascular Disease Foundation (VDF) is pleased to announce that Thomas R. Frieden, MD, MPH, Director, Centers for Disease Control and Prevention will be the keynote speaker at its annual meeting, "Current Issues in Vascular Disease" September 14-15 in McLean, VA.

28 Jul 2011

22nd Century receives FDA approval for X-22 IND to conduct Phase II-B smoking cessation trial

22nd Century Group, Inc., a company focused on smoking cessation and tobacco harm reduction products, today announced that the U.S. Food & Drug Administration (FDA) has cleared an Investigational New Drug (IND) Application to conduct a Phase II-B clinical trial using X-22, a prescription smoking cessation aid in development.

22 Jul 2011

Perrigo's coated cinnamon nicotine gum receives FDA marketing approval

The Perrigo Company today announced that it has received approval from the U.S. Food and Drug Administration (FDA) to market over-the-counter coated nicotine polacrilex gum USP, 2 mg and 4 mg cinnamon flavor.

22 Jul 2011

Researchers find clear changes in how emotions are processed in smokers

A team of researchers led by the University of Bonn found clear changes in how emotions are processed in smokers. After an abstinence period of 12 hours, the brain's fear center was mostly out of commission in addicts.

12 Jul 2011

New CRM simulation model for Canadian Partnership Against Cancer

If Canada's smoking rates were cut by half to an average national rate of 11% within five years, it would result in 35,900 fewer cases of lung cancer by 2030 and save $656 million in treatment costs, according to analysis using a new web-enabled platform developed for the Canadian Partnership Against Cancer and presented at the 14th World Conference on Lung Cancer in Amsterdam, hosted by the International Association for the Study of Lung Cancer.

6 Jul 2011

Maternal smoking cessation improves perinatal outcomes in children

Low birthweight is the most common negative outcome of smoking during pregnancy, but foetuses exposed to maternal smoking are also at risk of premature birth and the associated problem of brain damage, as well as congenital abnormalities such as cleft lip.

6 Jul 2011

Varenicline may increase risk of adverse cardiovascular events among smokers

The use of varenicline to stop smoking is associated with a 72% increased risk of a serious adverse cardiovascular event, states an article in CMAJ.

5 Jul 2011

International Association for the Study of Lung Cancer welcomes publication of NLST results

The International Association for the Study of Lung Cancer (IASLC) today welcomed the publication of positive results of the National Lung Screening Trial.

2 Jul 2011

Low-dose spiral CT scan can decrease mortality from lung cancer

Current or heavy smokers who were screened with low-dose spiral computed tomography (CT) scanning had a 20 percent reduction in deaths from lung cancer than did those who were screened by chest X-ray, according to results from a decade-long, large clinical trial that involved more than 53,000 people.

1 Jul 2011

Smoking ban on Stony Stratford streets

A Buckinghamshire town is considering banning smoking from its streets. Stony Stratford town councilor Paul Bartlett is spearheading a campaign which would forbid residents from smoking on the streets.

1 Jul 2011

Text messages help smokers quit: Study

A behavioral study has found that motivational text messages sent to smokers' mobile phones can double their chances of giving up tobacco. The “txt2stop” trial at London School of Hygiene and Tropical Medicine (LSHTM) and funded by the Medical Research Council tested the effects of inspirational text messages designed to encourage quitting on almost 3,000 smokers. Participants were twice as likely to banish their habit as another group sent texts unrelated to smoking.

30 Jun 2011

NLST: CT screening reduces lung cancer specific mortality by 20%

Current and former heavy smokers can now be screened more effectively for lung cancer. Results from the National Lung Screening Trial (NLST) revealed that detecting small lung cancers with computed tomography (CT) reduces lung cancer specific mortality by 20 percent.

30 Jun 2011

Mobile phone text messages help smokers to beat addiction

Mobile phones could hold the key to people giving up smoking after a programme involving sending motivational and supportive text messages to smokers doubled quit rates at six months.

30 Jun 2011

NLST: CT scans more effective in reducing lung cancer death rates

The National Lung Screening Trial (NLST) is the first scientific study that provides clear evidence that CT screening significantly reduces the death rate due to lung cancer.

30 Jun 2011

22nd Century submits IND to FDA for VLN cigarettes

22nd Century Group, Inc., a company focused on smoking cessation and tobacco harm reduction, announced today that 22nd Century Limited, LLC submitted an Investigational New Drug Application (IND) to the U.S. Food & Drug Administration (FDA) for X-22, a prescription smoking cessation aid in development.

22 Jun 2011